Skip to main content

21.08.2018 | Original Research

Practice Variation among an International Group of Genetic Counselors on when to Offer Predictive Genetic Testing to Children at Risk of an Inherited Arrhythmia or Cardiomyopathy

verfasst von: S. Christian, M. Somerville, C. Huculak, J. Atallah

Erschienen in: Journal of Genetic Counseling

Einloggen, um Zugang zu erhalten

Abstract

Cascade predictive genetic testing is available for many families as a means to identify individuals at risk of long QT syndrome (LQTS), catecholaminergic polymorphic ventricular tachycardia (CPVT), hypertrophic cardiomyopathy (HCM), and arrhythmogenic right ventricular cardiomyopathy (ARVC). The general issue of offering predictive genetic testing to minors has been an area of ethical debate among genetic counselors and other healthcare professionals for many years. An online questionnaire was circulated to four international genetic counseling associations to assess the views of cardiac genetic counselors regarding when to offer predictive genetic testing to children at risk of LQTS, CPVT, HCM, and ARVC. Analysis was both quantitative and qualitative. The study sample comprised 98 respondents. The majority reported that they offer predictive genetic testing before 5 years of age to children at risk of LQTS (83%) and CVPT (75%) and before 10 years of age to children at risk of HCM (66%) or ARVC (70%). Influencing factors included country of practice, clinical setting, and years of experience. The rationale provided for when to offer predictive genetic testing is encompassed by the ethical principles of beneficence, non-maleficence, autonomy, and informed consent. In conclusion, significant practice variation exists among cardiac genetic counselors regarding predictive genetic testing for children at risk of an inherited cardiomyopathy. These variations call for more research in the area to assist with the development of evidence-based guidelines.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Ackerman, M. J., Priori, S. G., Willems, S., Berul, C., Brugada, R., Calkins, H., et al. (2011). HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm, 8(8), 1308–1339.CrossRefPubMed Ackerman, M. J., Priori, S. G., Willems, S., Berul, C., Brugada, R., Calkins, H., et al. (2011). HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm, 8(8), 1308–1339.CrossRefPubMed
Zurück zum Zitat Ackerman, M. J., Zipes, D. P., Kovacs, R. J., & Maron, B. J. (2015). Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 10: the cardiac channelopathies: a scientific statement from the American heart association and American college of cardiology. Journal of the American College of Cardiology, 66(21), 2424–2428.CrossRefPubMed Ackerman, M. J., Zipes, D. P., Kovacs, R. J., & Maron, B. J. (2015). Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 10: the cardiac channelopathies: a scientific statement from the American heart association and American college of cardiology. Journal of the American College of Cardiology, 66(21), 2424–2428.CrossRefPubMed
Zurück zum Zitat Alderfer, M. A., Lindell, R. B., Viadro, C. I., Zelley, K., Valdez, J., Mandrell, B., et al. (2017). Should genetic testing be offered for children? The perspectives of adolescents and emerging adults in families with li-Fraumeni syndrome. Journal of Genetic Counseling, 26(5), 1106–1115.CrossRefPubMed Alderfer, M. A., Lindell, R. B., Viadro, C. I., Zelley, K., Valdez, J., Mandrell, B., et al. (2017). Should genetic testing be offered for children? The perspectives of adolescents and emerging adults in families with li-Fraumeni syndrome. Journal of Genetic Counseling, 26(5), 1106–1115.CrossRefPubMed
Zurück zum Zitat American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) Task Force on Practice Guidelines, American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, et al. (2011). 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. The Journal of Thoracic and Cardiovascular Surgery, 142(6), 1303–1338.CrossRef American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) Task Force on Practice Guidelines, American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, et al. (2011). 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. The Journal of Thoracic and Cardiovascular Surgery, 142(6), 1303–1338.CrossRef
Zurück zum Zitat American Society of Clinical Oncology (ASCO). (2003). American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. Journal of Clinical Oncology, 21(12), 2397–2406.CrossRef American Society of Clinical Oncology (ASCO). (2003). American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. Journal of Clinical Oncology, 21(12), 2397–2406.CrossRef
Zurück zum Zitat Bonner, C., Spinks, C., Semsarian, C., Barratt, A., Ingles, J., & McCaffery, K. (2018). Psychosocial impact of a positive gene result for asymptomatic relatives at risk of hypertrophic cardiomyopathy. Journal of Genetic Counseling. https://doi.org/10.1007/s10897-018-0218-8 . Bonner, C., Spinks, C., Semsarian, C., Barratt, A., Ingles, J., & McCaffery, K. (2018). Psychosocial impact of a positive gene result for asymptomatic relatives at risk of hypertrophic cardiomyopathy. Journal of Genetic Counseling. https://​doi.​org/​10.​1007/​s10897-018-0218-8 .
Zurück zum Zitat Borry, P., Stultiens, L., Nys, H., Cassiman, J. J., & Dierickx, K. (2006). Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clinical Genetics, 70(5), 374–381.CrossRefPubMed Borry, P., Stultiens, L., Nys, H., Cassiman, J. J., & Dierickx, K. (2006). Presymptomatic and predictive genetic testing in minors: a systematic review of guidelines and position papers. Clinical Genetics, 70(5), 374–381.CrossRefPubMed
Zurück zum Zitat Botkin, J. R., Belmont, J. W., Berg, J. S., Berkman, B. E., Bombard, Y., Holm, I. A., et al. (2015). Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Journal of Human Genetics, 97(1), 6–21.CrossRefPubMedPubMedCentral Botkin, J. R., Belmont, J. W., Berg, J. S., Berkman, B. E., Bombard, Y., Holm, I. A., et al. (2015). Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Journal of Human Genetics, 97(1), 6–21.CrossRefPubMedPubMedCentral
Zurück zum Zitat Boycott, K., Hartley, T., Adam, S., Bernier, F., Chong, K., Fernandez, B. A., et al. (2015). The clinical application of genome-wide sequencing for monogenic diseases in Canada: position statement of the Canadian College of Medical Geneticists. Journal of Medical Genetics, 52(7), 431–437.CrossRefPubMedPubMedCentral Boycott, K., Hartley, T., Adam, S., Bernier, F., Chong, K., Fernandez, B. A., et al. (2015). The clinical application of genome-wide sequencing for monogenic diseases in Canada: position statement of the Canadian College of Medical Geneticists. Journal of Medical Genetics, 52(7), 431–437.CrossRefPubMedPubMedCentral
Zurück zum Zitat Bratt, E. L., Ostman-Smith, I., Sparud-Lundin, C., & Axelsson, B. A. (2011). Parents’ experiences of having an asymptomatic child diagnosed with hypertrophic cardiomyopathy through family screening. Cardiology in the Young, 21(1), 8–14.CrossRefPubMed Bratt, E. L., Ostman-Smith, I., Sparud-Lundin, C., & Axelsson, B. A. (2011). Parents’ experiences of having an asymptomatic child diagnosed with hypertrophic cardiomyopathy through family screening. Cardiology in the Young, 21(1), 8–14.CrossRefPubMed
Zurück zum Zitat Bratt, E. L., Sparud-Lundin, C., Ostman-Smith, I., & Axelsson, A. B. (2012). The experience of being diagnosed with hypertrophic cardiomyopathy through family screening in childhood and adolescence. Cardiology in the Young, 22(5), 528–535.CrossRefPubMed Bratt, E. L., Sparud-Lundin, C., Ostman-Smith, I., & Axelsson, A. B. (2012). The experience of being diagnosed with hypertrophic cardiomyopathy through family screening in childhood and adolescence. Cardiology in the Young, 22(5), 528–535.CrossRefPubMed
Zurück zum Zitat Charron, P., Arad, M., Arbustini, E., Basso, C., Bilinska, Z., Elliott, P., et al. (2010). Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology working group on myocardial and pericardial diseases. European Heart Journal, 31(22), 2715–2726.CrossRefPubMed Charron, P., Arad, M., Arbustini, E., Basso, C., Bilinska, Z., Elliott, P., et al. (2010). Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology working group on myocardial and pericardial diseases. European Heart Journal, 31(22), 2715–2726.CrossRefPubMed
Zurück zum Zitat Christian, S., Somerville, M., Taylor, S., & Atallah, J. (2016). Exercise and beta-blocker therapy recommendations for inherited arrhythmogenic conditions. Cardiology in the Young, 26(6), 1123–1129.CrossRefPubMed Christian, S., Somerville, M., Taylor, S., & Atallah, J. (2016). Exercise and beta-blocker therapy recommendations for inherited arrhythmogenic conditions. Cardiology in the Young, 26(6), 1123–1129.CrossRefPubMed
Zurück zum Zitat Corrado, D., Wichter, T., Link, M. S., Hauer, R., Marchlinski, F., Anastasakis, A., et al. (2015). Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement. European Heart Journal, 36(46), 3227–3237.PubMedPubMedCentral Corrado, D., Wichter, T., Link, M. S., Hauer, R., Marchlinski, F., Anastasakis, A., et al. (2015). Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement. European Heart Journal, 36(46), 3227–3237.PubMedPubMedCentral
Zurück zum Zitat Danzon, P. M. (1990). The “crisis” in medical malpractice: a comparison of trends in the United States, Canada, the United Kingdom and Australia. Law, Medicine & Health Care, 18(1–2), 48–58.CrossRef Danzon, P. M. (1990). The “crisis” in medical malpractice: a comparison of trends in the United States, Canada, the United Kingdom and Australia. Law, Medicine & Health Care, 18(1–2), 48–58.CrossRef
Zurück zum Zitat DiLorenzo, T. M., Bargman, E. P., Stucky-Ropp, R., Brassington, G. S., Frensch, P. A., & LaFontaine, T. (1999). Long-term effects of aerobic exercise on psychological outcomes. Preventive Medicine, 28(1), 75–85.CrossRefPubMed DiLorenzo, T. M., Bargman, E. P., Stucky-Ropp, R., Brassington, G. S., Frensch, P. A., & LaFontaine, T. (1999). Long-term effects of aerobic exercise on psychological outcomes. Preventive Medicine, 28(1), 75–85.CrossRefPubMed
Zurück zum Zitat Douma, K. F., Aaronson, N. K., Vasen, H., Verhoef, S., Gundy, C. M., & Bleiker, E. M. (2010). Attitudes toward genetic testing in childhood and reproductive decision-making for familial adenomatous polyposis. European Journal of Human Genetics, 18(2), 186–193.CrossRefPubMed Douma, K. F., Aaronson, N. K., Vasen, H., Verhoef, S., Gundy, C. M., & Bleiker, E. M. (2010). Attitudes toward genetic testing in childhood and reproductive decision-making for familial adenomatous polyposis. European Journal of Human Genetics, 18(2), 186–193.CrossRefPubMed
Zurück zum Zitat Dunbar, S. B., Dougherty, C. M., Sears, S. F., Carroll, D. L., Goldstein, N. E., Mark, D. B., et al. (2012). Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association. Circulation, 126(17), 2146–2172.CrossRefPubMed Dunbar, S. B., Dougherty, C. M., Sears, S. F., Carroll, D. L., Goldstein, N. E., Mark, D. B., et al. (2012). Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association. Circulation, 126(17), 2146–2172.CrossRefPubMed
Zurück zum Zitat Geelen, E., Van Hoyweghen, I., Doevendans, P. A., Marcelis, C. L., & Horstman, K. (2011). Constructing “best interests”: genetic testing of children in families with hypertrophic cardiomyopathy. American Journal of Medical Genetics, 155A(8), 1930–1938.CrossRefPubMed Geelen, E., Van Hoyweghen, I., Doevendans, P. A., Marcelis, C. L., & Horstman, K. (2011). Constructing “best interests”: genetic testing of children in families with hypertrophic cardiomyopathy. American Journal of Medical Genetics, 155A(8), 1930–1938.CrossRefPubMed
Zurück zum Zitat Gjone, H., Diseth, T. H., Fausa, O., Novik, T. S., & Heiberg, A. (2011). Familial adenomatous polyposis: mental health, psychosocial functioning and reactions to genetic risk in adolescents. Clinical Genetics, 79(1), 35–43.CrossRefPubMed Gjone, H., Diseth, T. H., Fausa, O., Novik, T. S., & Heiberg, A. (2011). Familial adenomatous polyposis: mental health, psychosocial functioning and reactions to genetic risk in adolescents. Clinical Genetics, 79(1), 35–43.CrossRefPubMed
Zurück zum Zitat Goldenberg, I., Moss, A. J., Peterson, D. R., McNitt, S., Zareba, W., Andrews, M. L., et al. (2008). Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation, 117(17), 2184–2191.CrossRefPubMedPubMedCentral Goldenberg, I., Moss, A. J., Peterson, D. R., McNitt, S., Zareba, W., Andrews, M. L., et al. (2008). Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation, 117(17), 2184–2191.CrossRefPubMedPubMedCentral
Zurück zum Zitat Gollob, M. H., Blier, L., Brugada, R., Champagne, J., Chauhan, V., Connors, S., et al. (2011). Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper. The Canadian Journal of Cardiology, 27(2), 232–245.CrossRefPubMed Gollob, M. H., Blier, L., Brugada, R., Champagne, J., Chauhan, V., Connors, S., et al. (2011). Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper. The Canadian Journal of Cardiology, 27(2), 232–245.CrossRefPubMed
Zurück zum Zitat Hehir-Kwa, J. Y., Claustres, M., Hastings, R. J., van Ravenswaaij-Arts, C., Christenhusz, G., Genuardi, M., et al. (2015). Towards a European consensus for reporting incidental findings during clinical NGS testing. European Journal of Human Genetics, 23(12), 1601–1606.CrossRefPubMedPubMedCentral Hehir-Kwa, J. Y., Claustres, M., Hastings, R. J., van Ravenswaaij-Arts, C., Christenhusz, G., Genuardi, M., et al. (2015). Towards a European consensus for reporting incidental findings during clinical NGS testing. European Journal of Human Genetics, 23(12), 1601–1606.CrossRefPubMedPubMedCentral
Zurück zum Zitat Hein, I. M., Troost, P. W., Lindeboom, R., Christiaans, I., Grisso, T., van Goudoever, J. B., et al. (2015). Feasibility of an assessment tool for children's competence to consent to predictive genetic testing: a pilot study. Journal of Genetic Counseling, 24(6), 971–977.CrossRefPubMedPubMedCentral Hein, I. M., Troost, P. W., Lindeboom, R., Christiaans, I., Grisso, T., van Goudoever, J. B., et al. (2015). Feasibility of an assessment tool for children's competence to consent to predictive genetic testing: a pilot study. Journal of Genetic Counseling, 24(6), 971–977.CrossRefPubMedPubMedCentral
Zurück zum Zitat Helmrich, S. P., Ragland, D. R., Leung, R. W., & Paffenbarger Jr., R. S. (1991). Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. The New England Journal of Medicine, 325(3), 147–152.CrossRefPubMed Helmrich, S. P., Ragland, D. R., Leung, R. W., & Paffenbarger Jr., R. S. (1991). Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. The New England Journal of Medicine, 325(3), 147–152.CrossRefPubMed
Zurück zum Zitat Hershberger, R. E., Givertz, M., Ho, C. Y., Judge, D. P., Kantor, P., McBride, K. L., et al. (2018). Genetic evaluation of cardiomyopathy—a Heart Failure Society of America practice guideline. Journal of Cardiac Failure. Hershberger, R. E., Givertz, M., Ho, C. Y., Judge, D. P., Kantor, P., McBride, K. L., et al. (2018). Genetic evaluation of cardiomyopathy—a Heart Failure Society of America practice guideline. Journal of Cardiac Failure.
Zurück zum Zitat Ingles, J., Zodgekar, P. R., Yeates, L., Macciocca, I., Semsarian, C., & Fatkins, D. (2011). Guidelines for genetic testing of inherited cardiac disorders. Heart, Lung & Circulation, 20(11), 681–687.CrossRef Ingles, J., Zodgekar, P. R., Yeates, L., Macciocca, I., Semsarian, C., & Fatkins, D. (2011). Guidelines for genetic testing of inherited cardiac disorders. Heart, Lung & Circulation, 20(11), 681–687.CrossRef
Zurück zum Zitat Iyer, V. R., & Chin, A. J. (2013). Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D). American Journal of Medical Genetics. Part A, 163C(3), 185–197.CrossRef Iyer, V. R., & Chin, A. J. (2013). Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D). American Journal of Medical Genetics. Part A, 163C(3), 185–197.CrossRef
Zurück zum Zitat James, C. A., Bhonsale, A., Tichnell, C., Murray, B., Russell, S. D., Tandri, H., et al. (2013). Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. Journal of the American College of Cardiology, 62(14), 1290–1297.CrossRefPubMed James, C. A., Bhonsale, A., Tichnell, C., Murray, B., Russell, S. D., Tandri, H., et al. (2013). Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. Journal of the American College of Cardiology, 62(14), 1290–1297.CrossRefPubMed
Zurück zum Zitat Kalia, S. S., Adelman, K., Bale, S. J., Chung, W. K., Eng, C., Evans, J. P., et al. (2017). Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genetics in Medicine, 19(2), 249–255.CrossRefPubMed Kalia, S. S., Adelman, K., Bale, S. J., Chung, W. K., Eng, C., Evans, J. P., et al. (2017). Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genetics in Medicine, 19(2), 249–255.CrossRefPubMed
Zurück zum Zitat Kirchhof, P., Fabritz, L., Zwiener, M., Witt, H., Schafers, M., Zellerhoff, S., et al. (2006). Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation, 114(17), 1799–1806.CrossRefPubMed Kirchhof, P., Fabritz, L., Zwiener, M., Witt, H., Schafers, M., Zellerhoff, S., et al. (2006). Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation, 114(17), 1799–1806.CrossRefPubMed
Zurück zum Zitat Koponen, M., Marjamaa, A., Hiippala, A., Happonen, J. M., Havulinna, A. S., Salomaa, V., et al. (2015). Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: Clinical course, treatments, and side effects. Circulation. Arrhythmia and Electrophysiology, 8(4), 815–823.CrossRefPubMed Koponen, M., Marjamaa, A., Hiippala, A., Happonen, J. M., Havulinna, A. S., Salomaa, V., et al. (2015). Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: Clinical course, treatments, and side effects. Circulation. Arrhythmia and Electrophysiology, 8(4), 815–823.CrossRefPubMed
Zurück zum Zitat Mammen, G., & Faulkner, G. (2013). Physical activity and the prevention of depression: a systematic review of prospective studies. American Journal of Preventive Medicine, 45(5), 649–657.CrossRefPubMed Mammen, G., & Faulkner, G. (2013). Physical activity and the prevention of depression: a systematic review of prospective studies. American Journal of Preventive Medicine, 45(5), 649–657.CrossRefPubMed
Zurück zum Zitat Maron, B. J., Chaitman, B. R., Ackerman, M. J., Bayes de Luna, A., Corrado, D., Crosson, J. E., et al. (2004). Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation, 109(22), 2807–2816.CrossRefPubMed Maron, B. J., Chaitman, B. R., Ackerman, M. J., Bayes de Luna, A., Corrado, D., Crosson, J. E., et al. (2004). Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation, 109(22), 2807–2816.CrossRefPubMed
Zurück zum Zitat Maron, B. J., Ackerman, M. J., Nishimura, R. A., Pyeritz, R. E., Towbin, J. A., & Udelson, J. E. (2005). Task force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and marfan syndrome. Journal of the American College of Cardiology, 45(8), 1340–1345.CrossRefPubMed Maron, B. J., Ackerman, M. J., Nishimura, R. A., Pyeritz, R. E., Towbin, J. A., & Udelson, J. E. (2005). Task force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and marfan syndrome. Journal of the American College of Cardiology, 45(8), 1340–1345.CrossRefPubMed
Zurück zum Zitat Maron, B. J., Udelson, J. E., Bonow, R. O., Nishimura, R. A., Ackerman, M. J., Estes 3rd, N. A., et al. (2015). Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. Circulation, 132(22), e273–e280.CrossRefPubMed Maron, B. J., Udelson, J. E., Bonow, R. O., Nishimura, R. A., Ackerman, M. J., Estes 3rd, N. A., et al. (2015). Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. Circulation, 132(22), e273–e280.CrossRefPubMed
Zurück zum Zitat Meulenkamp, T. M., Tibben, A., Mollema, E. D., van Langen, I. M., Wiegman, A., de Wert, G. M., et al. (2008). Predictive genetic testing for cardiovascular diseases: impact on carrier children. American Journal of Medical Genetics. Part A, 146A(24), 3136–3146.CrossRefPubMed Meulenkamp, T. M., Tibben, A., Mollema, E. D., van Langen, I. M., Wiegman, A., de Wert, G. M., et al. (2008). Predictive genetic testing for cardiovascular diseases: impact on carrier children. American Journal of Medical Genetics. Part A, 146A(24), 3136–3146.CrossRefPubMed
Zurück zum Zitat Michie, S., Bobrow, M., & Marteau, T. M. (2001). Predictive genetic testing in children and adults: a study of emotional impact. Journal of Medical Genetics, 38(8), 519–526.CrossRefPubMedPubMedCentral Michie, S., Bobrow, M., & Marteau, T. M. (2001). Predictive genetic testing in children and adults: a study of emotional impact. Journal of Medical Genetics, 38(8), 519–526.CrossRefPubMedPubMedCentral
Zurück zum Zitat Mohammed, S., Lim, Z., Dean, P., Potts, J. E., Tang, J. N., Etheridge, S. P., et al. (2017). Genetic insurance discrimination in sudden arrhythmia death syndromes: empirical evidence from a cross-sectional survey in North America. Circulation. Cardiovascular Genetics, 10(1), e001442.CrossRefPubMed Mohammed, S., Lim, Z., Dean, P., Potts, J. E., Tang, J. N., Etheridge, S. P., et al. (2017). Genetic insurance discrimination in sudden arrhythmia death syndromes: empirical evidence from a cross-sectional survey in North America. Circulation. Cardiovascular Genetics, 10(1), e001442.CrossRefPubMed
Zurück zum Zitat Monico, E. P., Calise, A., & Calabro, J. (2008). Torts to contract? Moving from informed consent to shared decision-making. Journal of Healthcare Risk Management, 28(4), 7–9.CrossRefPubMed Monico, E. P., Calise, A., & Calabro, J. (2008). Torts to contract? Moving from informed consent to shared decision-making. Journal of Healthcare Risk Management, 28(4), 7–9.CrossRefPubMed
Zurück zum Zitat Nocon, M., Hiemann, T., Muller-Riemenschneider, F., Thalau, F., Roll, S., & Willich, S. N. (2008). Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. European Journal of Cardiovascular Prevention and Rehabilitation, 15(3), 239–246.CrossRefPubMed Nocon, M., Hiemann, T., Muller-Riemenschneider, F., Thalau, F., Roll, S., & Willich, S. N. (2008). Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. European Journal of Cardiovascular Prevention and Rehabilitation, 15(3), 239–246.CrossRefPubMed
Zurück zum Zitat Pelliccia, A., Fagard, R., Bjornstad, H. H., Anastassakis, A., Arbustini, E., Assanelli, D., et al. (2005). Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the study group of sports cardiology of the working group of cardiac rehabilitation and exercise physiology and the working group of myocardial and pericardial diseases of the European Society of Cardiology. European Heart Journal, 26(14), 1422–1445.CrossRefPubMed Pelliccia, A., Fagard, R., Bjornstad, H. H., Anastassakis, A., Arbustini, E., Assanelli, D., et al. (2005). Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the study group of sports cardiology of the working group of cardiac rehabilitation and exercise physiology and the working group of myocardial and pericardial diseases of the European Society of Cardiology. European Heart Journal, 26(14), 1422–1445.CrossRefPubMed
Zurück zum Zitat Postma, A. V., Denjoy, I., Kamblock, J., Alders, M., Lupoglazoff, J. M., Vaksmann, G., et al. (2005). Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. Journal of Medical Genetics, 42(11), 863–870.CrossRefPubMedPubMedCentral Postma, A. V., Denjoy, I., Kamblock, J., Alders, M., Lupoglazoff, J. M., Vaksmann, G., et al. (2005). Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. Journal of Medical Genetics, 42(11), 863–870.CrossRefPubMedPubMedCentral
Zurück zum Zitat Saberniak, J., Hasselberg, N. E., Borgquist, R., Platonov, P. G., Sarvari, S. I., Smith, H. J., et al. (2014). Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members. European Journal of Heart Failure, 16(12), 1337–1344.CrossRefPubMedPubMedCentral Saberniak, J., Hasselberg, N. E., Borgquist, R., Platonov, P. G., Sarvari, S. I., Smith, H. J., et al. (2014). Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members. European Journal of Heart Failure, 16(12), 1337–1344.CrossRefPubMedPubMedCentral
Zurück zum Zitat Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., et al. (2014). 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). European Heart Journal, 35(39), 2733–2779.CrossRef Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., et al. (2014). 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). European Heart Journal, 35(39), 2733–2779.CrossRef
Zurück zum Zitat Villain, E., Denjoy, I., Lupoglazoff, J. M., Guicheney, P., Hainque, B., Lucet, V., et al. (2004). Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome. European Heart Journal, 25(16), 1405–1411.CrossRefPubMed Villain, E., Denjoy, I., Lupoglazoff, J. M., Guicheney, P., Hainque, B., Lucet, V., et al. (2004). Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome. European Heart Journal, 25(16), 1405–1411.CrossRefPubMed
Zurück zum Zitat Wade, C. H., Wilfond, B. S., & McBride, C. M. (2010). Effects of genetic risk information on children’s psychosocial wellbeing: a systematic review of the literature. Genetics Medicine, 12(6), 317–326.CrossRef Wade, C. H., Wilfond, B. S., & McBride, C. M. (2010). Effects of genetic risk information on children’s psychosocial wellbeing: a systematic review of the literature. Genetics Medicine, 12(6), 317–326.CrossRef
Zurück zum Zitat Wakefield, C. E., Hanlon, L. V., Tucker, K. M., Patenaude, A. F., Signorelli, C., McLoone, J. K., et al. (2016). The psychological impact of genetic information on children: a systematic review. Genetics Medicine, 18(8), 755–762.CrossRef Wakefield, C. E., Hanlon, L. V., Tucker, K. M., Patenaude, A. F., Signorelli, C., McLoone, J. K., et al. (2016). The psychological impact of genetic information on children: a systematic review. Genetics Medicine, 18(8), 755–762.CrossRef
Zurück zum Zitat Wynn, J., Martinez, J., Bulafka, J., Duong, J., Zhang, Y., Chiuzan, C., et al. (2018). Impact of receiving secondary results from genomic research: a 12-month longitudinal study. Journal of Genetic Counseling, 27(3), 709–722.CrossRefPubMed Wynn, J., Martinez, J., Bulafka, J., Duong, J., Zhang, Y., Chiuzan, C., et al. (2018). Impact of receiving secondary results from genomic research: a 12-month longitudinal study. Journal of Genetic Counseling, 27(3), 709–722.CrossRefPubMed
Metadaten
Titel
Practice Variation among an International Group of Genetic Counselors on when to Offer Predictive Genetic Testing to Children at Risk of an Inherited Arrhythmia or Cardiomyopathy
verfasst von
S. Christian
M. Somerville
C. Huculak
J. Atallah
Publikationsdatum
21.08.2018
Verlag
Springer US
Erschienen in
Journal of Genetic Counseling
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-018-0293-x

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.